Discover and read the best of Twitter Threads about #acc19

Most recents (5)

As @DrMarthaGulati destroys her competition today at #ACC19 , there really is no worthy debate on whether a physician should participate in #SoMe or not.

A thread on where physicians need to obtain #SoMe skills and lead...
The principles of advocacy.

Op-ed piece by Dr. LeeAnne Luft:
ncbi.nlm.nih.gov/pmc/articles/P…

Call to action by Dr. Angira Patel @sciam blogs.scientificamerican.com/observations/i…

Eye-opening @ETSshow podcast w/ @PeterHotez explorethespaceshow.com/podcasting/pet…
Novel uses of #SoMe & documentation of impact.

#Tweetorials perspective by @Doctor_V 33charts.com/tweetorial/

Article on Physician exemplars ( incl. @EricTopol @SeattleMamaDoc )
patientpop.com/blog/marketing…

#SoMe portfolios for academics jgme.org/doi/full/10.43…
Read 5 tweets
Do you use #whyCMR in your patients undergoing #TAVR. More slides in the thread #CVimaging #ACCImaging #ACC19
Annular assessment by #whyCMR accuracy similar to #YesCCT

data from @JACCJournals
#ACCimaging #ACC19 #Cvimaging
Peripheral calcification is the limitation for #whyCMR use in #TAVR #ACCimaging #CVimaging #ACC19
Read 7 tweets
#ACC19 #LBCT
@PCRonline
1PANACHE: Safety:Efficacy of Neladenoson Bialanate, Partial Adenosine A1 Receptor Agonist, in CHF & Preserved EF: PANACHE RCT

2PIONEER-HF: Initiation of Angiotensin-Neprilysin Inhibition after Acute Decomp CHF: Open-Label Extension of
PIONEER-HF Trial
3 Hopeful Heart Trial: Blended Collaborative Care for Treating ❤️Failure & Comorbid Depression: 12-Month Outcomes

4 CODIACS-QoL: Randomized Trial of Depression Screening After ACS: Comparison of Depression Identification After ACS-QOL & Cost Effectiveness
5 PARTNER 3: #TAVR or SAVR in Low-Risk Patients: Results of the PARTNER 3 Trial

6 Self-Expanding #TAVR or SAVR in Patients at Low Risk of Surgical Mortality

7 Outcomes of #TAVR with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of STS/TVT Registry
Read 12 tweets
The countdown to #ACC19 has begun!

Here’s a THREAD about the much anticipated #AppleHeartStudy

(results to be presented at 9am THIS Saturday, March 17 at #ACC19 by #EPeeps Mintu Turakhia AKA @leftbundle from @SCCR_Stanford!)

#ACCEP
The #AppleHeartStudy aimed to test the ability of a smartwatch algorithm to detect an irregular pulse consistent with AF, & to estimate its diagnostic yield in a large population:
#ACC19 #ACCEP
The cool thing about the #AppleHeartStudy, is that all of it was done virtually. ALL. OF. IT. Enrollment, consent, study visits, patch monitoring. Here are the #AppleHeartStudy ‘s main objectives in detail:
#ACC19 #ACCEP
Read 15 tweets
Two noteworthy findings by Wang @rkwadhera @DLBHATTMD in @JAMACardio:
1) Hospitals in the @usnews top 50 have better mortality rates than other hospitals in AMI, CABG & HF. Better HCAHPS, too. Not too surprising, but certainly reassuring.
2) But...
jamanetwork.com/journals/jamac…

1/
2) But those same top hospitals do no better than others on readmission.

Why? Well, we have to ask ourselves whether readmission is a valid indicator of quality. And if it is, is it valid in all patient cohorts, or only certain ones?
2/
As Wang @rkwadhera @DLBHATTMD understatedly write:

“The observed discrepancy between readmissions and other performance measures raises concern that readmissions may not be an adequate metric of hospital care quality.”
3/
Read 12 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!